NIH-funded research NIH-funded research

ecDNA in Cancer: Understanding and targeting circular DNA that drives tumor growth

Official title: eDyNAmiC (extrachromosomal DNA in Cancer) - Understanding the biology of ecDNA generation and action, and developing new ways to target these mechanisms in cancer

Funded at Sloan-Kettering Inst Can Research · NIH-11539609 · Data updated 2026-11-12

A cancer-focused project to understand how extrachromosomal DNA helps tumors grow and resist treatment, and to develop new ways to target these mechanisms.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2024
Project endMay 31, 2027
Funding year2026
Award (this year)$292,861
NIH project number3OT2CA301085-01S2
Project IDNIH-11539609 on NIH RePORTER

Who could benefit from this research

Could help

Patients whose tumors harbor ecDNA or who have cancers known to frequently carry ecDNA.

Less likely to help

Patients without ecDNA-driven cancers may not benefit from this specific targeting approach.

What this research studies

This project studies ecDNA, circular DNA pieces that carry cancer-promoting genes and can spread quickly within tumors. Researchers will map how ecDNA forms, moves, and regulates oncogenes, and test strategies to disrupt these processes. By combining insights from cancer biology and innovative targeting approaches, the work aims to make ecDNA-driven cancers more treatable. The effort brings together international experts and uses advanced genomic and molecular methods to understand why ecDNA-containing cancers are so aggressive.

Why it matters

Potential benefit: If successful, patients with ecDNA-positive cancers could have new treatment options that slow tumor growth and overcome resistance to therapy.

How similar studies have gone: Other studies have shown ecDNA contributes to cancer aggressiveness, supporting a potential for meaningful advances with targeted strategies.

Where this research is happening

  • Sloan-Kettering Inst Can Research
    New York, United States
    Active

Researchers

  • Principal investigator: Ventura, Andrea — Sloan-Kettering Inst Can Research
  • Study coordinator: Ventura, Andrea

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.